|
|
||||||||
J Thorac Cardiovasc Surg 2009;138:1073-1080
© 2009 The American Association for Thoracic Surgery
Acquired Cardiovascular Disease |
Clinic for Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
Received for publication April 23, 2009; revisions received June 22, 2009; accepted for publication July 13, 2009. * Address for reprints: Sabine Bleiziffer, MD, Clinic for Cardiovascular Surgery, German Heart Center Munich, Lazarettstr 36, 80636 Munich, Germany. (Email: bleiziffer{at}dhm.mhn.de).
Objective: Recently, suspicion had been expressed that survival might be impaired after antegrade transapical as opposed to retrograde transfemoral valve implantation in high-risk patients with aortic stenosis. We analyzed survival in patients undergoing transcatheter aortic valve implantation with special emphasis on the access site for implantation.
Methods: Between June 2007 and February 2009, 203 high-risk patients (EuroSCORE, 22% ± 14%; mean age, 81 ± 7 years) underwent transcatheter aortic valve implantation via a transapical (n = 50) or transfemoral (n = 153) access. The transapical implantation technique was chosen only in patients who had no access through diseased femoral arteries.
Results: Thirty-day survival was 88.8% after transfemoral versus 91.7% after transapical implantation (P = .918). The transapical group had a significantly higher preoperative brain natriuretic peptide value and a significantly higher incidence of peripheral vessel, cerebrovascular, and coronary heart disease. Death within 30 days was valve related in 25% (transapical) and 31% (transfemoral), cardiac in 25% and 13%, and noncardiac in 50% and 56%, respectively (no significant difference). Complications specific to the access site (peripheral vessel injury or apex complications) occurred in both groups, whereas neurologic events did not occur in the transapical group (P = .041).
Conclusions: Our patient and access site selection process, with the transfemoral technique considered the access site of first choice, results in comparable survival and morbidity for either transfemoral or transapical transcatheter aortic valve implantation. Both techniques are associated with certain access site–specific complications that require highly qualified management. The neurologic risk profile of the patients should be included in the decision-making process before transcatheter aortic valve implantation, inasmuch as neurologic events may be reduced with the transapical access.
This article has been cited by other articles:
![]() |
S. Bleiziffer, D. Mazzitelli, A. Opitz, I. Hettich, H. Ruge, N. Piazza, and R. Lange Beyond the short-term: Clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients J. Thorac. Cardiovasc. Surg., February 1, 2012; 143(2): 310 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, J. Kempfert, A. Rastan, M. A. Borger, A. Linke, J. Ender, G. Schuler, and F. W. Mohr Transapical aortic valve implantation at 3 years J. Thorac. Cardiovasc. Surg., February 1, 2012; 143(2): 326 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Unbehaun, M. Pasic, S. Dreysse, T. Drews, M. Kukucka, A. Mladenow, E. Ivanitskaja-Kuhn, R. Hetzer, and S. Buz Transapical Aortic Valve Implantation: Incidence and Predictors of Paravalvular Leakage and Transvalvular Regurgitation in a Series of 358 Patients J. Am. Coll. Cardiol., January 17, 2012; 59(3): 211 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D'Onofrio, M. Fusari, N. Abbiate, C. Zanchettin, R. Bianco, A. Fabbri, L. Salvador, E. Polesel, P. Biglioli, and G. Gerosa Transapical Aortic Valve Implantation in High-Risk Patients With Severe Aortic Valve Stenosis Ann. Thorac. Surg., November 1, 2011; 92(5): 1671 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Ewe, V. Delgado, A. C. T. Ng, M. L. Antoni, F. van der Kley, N. A. Marsan, A. de Weger, G. Tavilla, E. R. Holman, M. J. Schalij, et al. Outcomes After Transcatheter Aortic Valve Implantation: Transfemoral Versus Transapical Approach Ann. Thorac. Surg., October 1, 2011; 92(4): 1244 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Unbehaun, M. Pasic, T. Drews, S. Dreysse, M. Kukucka, R. Hetzer, and S. Buz Analysis of Survival in 300 High-Risk Patients up to 2.5 Years After Transapical Aortic Valve Implantation Ann. Thorac. Surg., October 1, 2011; 92(4): 1315 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., September 13, 2011; 58(12): 1197 - 1207. [Full Text] [PDF] |
||||
![]() |
J. Higgins, J. Ye, K. H. Humphries, A. Cheung, D. A. Wood, J. G. Webb, and S. V. Lichtenstein Early clinical outcomes after transapical aortic valve implantation: A propensity-matched comparison with conventional aortic valve replacement J. Thorac. Cardiovasc. Surg., August 1, 2011; 142(2): e47 - e52. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hayashida, T. Lefevre, B. Chevalier, T. Hovasse, M. Romano, P. Garot, D. Mylotte, J. Uribe, A. Farge, P. Donzeau-Gouge, et al. Transfemoral Aortic Valve Implantation: New Criteria to Predict Vascular Complications J. Am. Coll. Cardiol. Intv., August 1, 2011; 4(8): 851 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Buz, M. Pasic, A. Unbehaun, T. Drews, S. Dreysse, M. Kukucka, A. Mladenow, and R. Hetzer Trans-apical aortic valve implantation in patients with severe calcification of the ascending aorta Eur J Cardiothorac Surg, August 1, 2011; 40(2): 463 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bleiziffer, N. Piazza, D. Mazzitelli, A. Opitz, R. Bauernschmitt, and R. Lange Apical-access-related complications associated with trans-catheter aortic valve implantation Eur J Cardiothorac Surg, August 1, 2011; 40(2): 469 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thomas, G. Schymik, T. Walther, D. Himbert, T. Lefevre, H. Treede, H. Eggebrecht, P. Rubino, A. Colombo, R. Lange, et al. One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: The European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve Circulation, July 26, 2011; 124(4): 425 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Wendler, T. Walther, H. Schroefel, R. Lange, H. Treede, M. Fusari, P. Rubino, and M. Thomas The SOURCE Registry: what is the learning curve in trans-apical aortic valve implantation? Eur J Cardiothorac Surg, June 1, 2011; 39(6): 853 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bruschi, F. De Marco, P. Fratto, J. Oreglia, P. Colombo, L. Botta, S. Klugmann, and L. Martinelli Alternative approaches for trans-catheter self-expanding aortic bioprosthetic valves implantation: single-center experience Eur J Cardiothorac Surg, June 1, 2011; 39(6): e151 - e158. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Roselli Engineering Transcatheter Aortic Valve Devices: A Surgeon's Perspective Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, March 1, 2011; 225(3): 207 - 219. [Abstract] [PDF] |
||||
![]() |
M. B. Leon, N. Piazza, E. Nikolsky, E. H. Blackstone, D. E. Cutlip, A. P. Kappetein, M. W. Krucoff, M. Mack, R. Mehran, C. Miller, et al. Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials: A Consensus Report From the Valve Academic Research Consortium J. Am. Coll. Cardiol., January 18, 2011; 57(3): 253 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Leon, N. Piazza, E. Nikolsky, E. H. Blackstone, D. E. Cutlip, A. P. Kappetein, M. W. Krucoff, M. Mack, R. Mehran, C. Miller, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium Eur. Heart J., January 6, 2011; (2011) ehq406v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rodes-Cabau, E. Dumont, R. H. Boone, E. Larose, R. Bagur, R. Gurvitch, F. Bedard, D. Doyle, R. De Larochelliere, C. Jayasuria, et al. Cerebral Embolism Following Transcatheter Aortic Valve Implantation: Comparison of Transfemoral and Transapical Approaches J. Am. Coll. Cardiol., January 4, 2011; 57(1): 18 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Geisbusch, S. Bleiziffer, D. Mazzitelli, H. Ruge, R. Bauernschmitt, and R. Lange Incidence and Management of CoreValve Dislocation During Transcatheter Aortic Valve Implantation Circ Cardiovasc Interv, December 1, 2010; 3(6): 531 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pasic, S. Buz, S. Dreysse, T. Drews, A. Unbehaun, C. Klein, M. Kukucka, A. Mladenow, E. Ivanitskaia-Kuhn, and R. Hetzer Transapical Aortic Valve Implantation in 194 Patients: Problems, Complications, and Solutions Ann. Thorac. Surg., November 1, 2010; 90(5): 1463 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Godino, F. Maisano, M. Montorfano, A. Latib, A. Chieffo, I. Michev, R. Al-Lamee, M. Bande, M. Mussardo, F. Arioli, et al. Outcomes After Transcatheter Aortic Valve Implantation With Both Edwards-SAPIEN and CoreValve Devices in a Single Center: The Milan Experience J. Am. Coll. Cardiol. Intv., November 1, 2010; 3(11): 1110 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arnold, S. Schulz-Heise, S. Achenbach, S. Ott, A. Dorfler, D. Ropers, R. Feyrer, F. Einhaus, S. Loders, F. Mahmoud, et al. Embolic Cerebral Insults After Transapical Aortic Valve Implantation Detected by Magnetic Resonance Imaging J. Am. Coll. Cardiol. Intv., November 1, 2010; 3(11): 1126 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bruschi, F. De Marco, P. Fratto, J. Oreglia, P. Colombo, R. Paino, S. Klugmann, and L. Martinelli Direct aortic access through right minithoracotomy for implantation of self-expanding aortic bioprosthetic valves J. Thorac. Cardiovasc. Surg., September 1, 2010; 140(3): 715 - 717. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |